Drug profile · INN
lepirudin
REFLUDAN
lepirudin (REFLUDAN) is a thrombin inhibitor.
EMA: withdrawn Blood and blood forming organs (B01) B01AE02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — lepirudin
- Class
- Blood and blood forming organs (B01)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
lepirudin (REFLUDAN) is a thrombin inhibitor.
Key facts
INN lepirudin
Brand REFLUDAN
Mechanism Thrombin inhibitor
Target Prothrombin
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AE02
Mechanism of action
Thrombin inhibitor
Primary target: Prothrombin
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is lepirudin?
lepirudin (REFLUDAN) is a thrombin inhibitor.
What is the brand name for lepirudin?
REFLUDAN is a marketed brand name for lepirudin. Check FDA Drugs@FDA for the current US label holder and prescribing information.